Clinical trial
Phase 1 Trial of IFx-Hu2.0 to Evaluate Safety in Patients With Skin Cancer
NCT04925713 is registered in ClinicalTrials.gov with TuHURA Biosciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Trial of IFx-Hu2.0 to Evaluate Safety in Patients With Skin Cancer
- Lead sponsor
- TuHURA Biosciences, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 10, 2021
- Completion date
- March 10, 2022
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.